BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19159907)

  • 1. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
    J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
    Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease.
    Wang B; Liu M; Yan W; Mao J; Jiang D; Li H; Chen Y
    J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1768-77. PubMed ID: 23701284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
    Chiusolo P; Giammarco S; Bellesi S; Metafuni E; Piccirillo N; De Ritis D; Marietti S; Federica S; Laurenti L; Fianchi L; Hohaus S; Giuseppe L; Sica S
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):691-6. PubMed ID: 21984221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB; Schmiegelow K; Schroeder H
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.
    Jabeen S; Holmboe L; Alnæs GI; Andersen AM; Hall KS; Kristensen VN
    Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
    Ifergan I; Meller I; Issakov J; Assaraf YG
    Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
    Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
    Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between SNPs in genes involved in folate metabolism and preterm birth risk.
    Wang BJ; Liu MJ; Wang Y; Dai JR; Tao JY; Wang SN; Zhong N; Chen Y
    Genet Mol Res; 2015 Feb; 14(1):850-9. PubMed ID: 25730024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
    Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
    Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children.
    Sirachainan N; Wongruangsri S; Kajanachumpol S; Pakakasama S; Visudtibhan A; Nuchprayoon I; Lusawat A; Phudhicharoenrat S; Shuangshoti S; Hongeng S
    Cancer Detect Prev; 2008; 32(1):72-8. PubMed ID: 18406541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms.
    Semmler A; Linnebank M; Krex D; Götz A; Moskau S; Ziegler A; Simon M
    Cerebrovasc Dis; 2008; 26(4):425-9. PubMed ID: 18799873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on reduced folate carrier gene (RFC1) polymorphism in the southern and northern Chinese population].
    Pei LJ; Ren AG; Zhu HP; Hao L; Zhao WR; Li Z; Hou GW; Zhang BL; Jiang YY; Wu LM; Pan YJ; Zhang ML
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):499-502. PubMed ID: 15231126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
    Lambrecht L; Sleurs C; Labarque V; Dhooge C; Laenen A; Sinnaeve F; Renard M; Uyttebroeck A
    Pharmacogenomics; 2017 Jun; 18(8):787-795. PubMed ID: 28592186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
    Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.